Active substance
Results for the substance aclidinium bromide formoterol fumarate
2 results
About this active substance
The combination of aclidinium bromide and formoterol fumarate is used for the treatment of chronic obstructive pulmonary disease (COPD). It combines a long-acting bronchodilator (aclidinium) and a long-acting beta-agonist (formoterol), providing more effective symptom relief.
The medication is administered via inhalation, usually twice daily, using an inhaler device. The combination helps relax airway muscles and improve airflow, reducing symptoms such as shortness of breath and coughing.
Common side effects include dry mouth, headache, and throat irritation. In rare cases, allergic reactions, palpitations, or worsening of glaucoma and urinary retention may occur.
Patients should use this medication as directed by their doctor and avoid using it for acute breathing difficulties, as it is not a rescue treatment.
The medication is administered via inhalation, usually twice daily, using an inhaler device. The combination helps relax airway muscles and improve airflow, reducing symptoms such as shortness of breath and coughing.
Common side effects include dry mouth, headache, and throat irritation. In rare cases, allergic reactions, palpitations, or worsening of glaucoma and urinary retention may occur.
Patients should use this medication as directed by their doctor and avoid using it for acute breathing difficulties, as it is not a rescue treatment.